Synthetic Opioids: Navigating a Changing Landscape in the Treatment of Opioid Use Disorder
This 35-minute module focuses on how primary care providers can navigate the changing landscape of opioid use disorder in relation to synthetic opioids.
Search
COVID-19: Potential Implications for Individuals with Substance Use Disorders
As people across the U.S. and the rest of the world contend with coronavirus disease 2019 (COVID-19), this article warns that the research community should be alert to the possibility that it could hit some populations with substance use...
Vibrant and Healthy Kids: Aligning Science, Practice, and Policy to Advance Health Equity
Early experiences and life circumstances shape prenatal and early childhood development, with powerful impacts on the developing brain and body that shape health outcomes across the life course and can span generations. The preconception...
Best Practices for Successful Reentry for People Who Have Opioid Addictions
This fact sheet describes the best practices that community-based behavioural health, and probation and parole agencies can implement to ensure that reentry for people who have opioid addictions is safe and successful.
Field Guide to Drug Demand Reduction Program Development, 3rd ed.
The Field Guide to Drug Demand Reduction (DDR) Program Development is an annual publication by the U.S. Department of State primarily for its Embassy personnel abroad to guide in the development of substance use prevention and treatment...
Baltimore Mayor’s Heroin Treatment & Prevention Task Force Report
EXECUTIVE SUMMARY
In October 2014, Mayor Stephanie Rawlings-Blake convened the Heroin Treatment and Prevention Task Force to address the critical problem of opioid addiction in Baltimore City. The goal of the Task Force was to study the...
Buscar Tratamiento de Calidad para Trastornos de Uso de Sustancias
Esta hoja informativa se puede usar como una guía para las personas que buscan tratamiento de salud mental. Ofrece tres pasos necesarios para llevar a cabo antes de utilizar un centro de tratamiento, así como las cinco señales de un centro...
Annual Surveillance Report of Drug-Related Risks and Outcomes
This report presents information on four types of outcomes from the four different data sources:
- Opioid prescribing, 2006-2016, from QuintilesIMS Health®
- Drug use, misuse, and substance use disorder, 2014-2015, from the National Survey...
Medication for the Treatment of Alcohol Use Disorder
The National Institute on Alcohol Abuse and Alcoholism (NIAAA), the Health and Human Services US Government Department (HSS) and the Substance Abuse and Mental Health Services Administration (SAMHSA) have collaborated to create a manual on...
The American Society of Addiction Medicine Standards of Care
This document is a useful resource for physicians that manage care services of patients with drug use disorders and its related consequences. It is intended to support quality improvement activities conducted by health care provider systems...
A Socioecological Approach to Addressing Tobacco-Related Health Disparities
Tobacco use remains the nation’s leading cause of preventable premature death, including death from cancer, and progress in reducing tobacco use and related disease and death has not been equally distributed across population groups. This...
Addressing Alcohol Use Practice Manual
Risky alcohol use, defined as any level of alcohol consumption which increases the risk of harm to oneself or others, is both a substance use disorder and medical issue. Recognized as one of the leading preventable causes of death, risky...
Field Guide to Drug Demand Reduction Program Development, 2nd ed.
The Field Guide to Drug Demand Reduction (DDR) Development is an annual publication by the U.S. Department of State primarily for its Embassy personnel abroad to guide in the development of substance use prevention and treatment programming...
Clinical Practice Guidelines for the Management of Substance Use Disorders
This guideline represents a significant step toward improving the treatment and management of patients with substance use disorders (SUD) in the Department of Veterans Affairs (VA) and the Department of Defense (DoD). As with other clinical...
XR-Naltrexone: A Step-by-Step Guide
The Providers' Clinical Support System for Medication Assisted Treatment (PCSS-MAT) experts have recently created a virtual step-by-step XR-Naltrexone User Guide to assist you in your practice in treating opioid use disorder (OUD). XR...
Lethal Highs: How U.S. Customs and Border Protection Laboratories Are Protecting America from Designer Drugs
This article summarizes the work of the U.S. Department of Homeland Security Customs and Border Protection agency (CBP) in the area of counternarcotics. The CBP describes the challenges to addressing substance use when molecular...
